Global Alpha Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.8M	Sell	361,240 -228,895	-39%	-$17.9M	1.67%	32
2025 Q4	$46.6M	Sell	590,135 -40,455	-6%	-$3.5M	2.84%	9
2025 Q3	$57.8M	Sell	630,590 -231,500	-27%	-$18.9M	3.3%	8
2025 Q2	$56.3M	Buy	862,090 +126,500	+17%	+$8.24M	3.51%	8
2025 Q1	$49.2M	Buy	735,590 +111,040	+18%	+$6.63M	3.58%	6
2024 Q4	$34.5M	Buy	624,550 +88,100	+16%	+$5.06M	2.51%	16
2024 Q3	$32M	Buy	536,450 +9,500	+2%	+$580K	2.08%	23
2024 Q2	$33.6M	Buy	526,950 +136,200	+35%	+$8.84M	2.45%	16
2024 Q1	$27M	Sell	390,750 -191,678	-33%	-$11.6M	2.01%	22
2023 Q4	$32.1M	Buy	582,428 +56,900	+11%	+$3.13M	2.58%	14
2023 Q3	$30.5M	Buy	525,528 +72,200	+16%	+$4.17M	3.06%	11
2023 Q2	$24.4M	Sell	453,328 -9,633	-2%	-$427K	2.29%	22
2023 Q1	$18.4M	Buy	462,961 +13,430	+3%	+$566K	1.67%	26
2022 Q4	$18.1M	Buy	449,531 +30,200	+7%	+$1.13M	1.77%	25
2022 Q3	$13.5M	Buy	419,331 +95,600	+30%	+$3.27M	1.35%	30
2022 Q2	$9.61M	Sell	323,731 -26,500	-8%	-$764K	1.04%	32
2022 Q1	$9.85M	Buy	350,231 +65,400	+23%	+$2.44M	0.85%	35
2021 Q4	$13.1M	Buy	284,831 +220,399	+342%	+$9.47M	1.27%	31
2021 Q3	$2.12M	Buy	+64,432	New	+$2M	0.23%	35
2020 Q4	–	Sell	-258,946	Closed	-$7.3M	–	37
2020 Q3	$7.3M	Sell	258,946 -16,300	-6%	-$485K	1.12%	32
2020 Q2	$8.9M	Buy	275,246 +57,500	+26%	+$2.06M	1.41%	29
2020 Q1	$8.87M	Buy	217,746 +48,000	+28%	+$2.55M	1.6%	25
2019 Q4	$10.5M	Buy	169,746 +22,700	+15%	+$1.5M	1.55%	27
2019 Q3	$10.7M	Buy	147,046 +4,600	+3%	+$344K	1.86%	20
2019 Q2	$11.7M	Buy	142,446 +45,935	+48%	+$3.27M	2.04%	21
2019 Q1	$6.81M	Buy	+96,511	New	+$5.68M	1.3%	34